Adults aged @-@ years with MDD ( DSM-IV-TR ) and Montgomery-Asberg Depression Rating Scale ( MADRS ) total score @ were randomized ( @:@:@ ) to receive vortioxetine @ mg or @ mg or placebo once daily , with the primary efficacy end point being change from baseline at week @ in MADRS analyzed by mixed model for repeated measures .